Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

17 results
Display

The KJH: Sailing over the horizon

Kwon SW

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multiple myeloma with huge extramedullary plasmacytomas

Bae SY, Lee JJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Mutations in AML with a normal karyotype: NPM1 and FLT3-ITD, ready to use as a key prognosticator?

Kim HJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Erratum

No authors listed

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Is RARS-T a new disease entity or a subtype of RARS or ET?

Bang SM

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
National blood management system and the direction of government policy in Korea

Cho JE

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Complex translocation (8;8;21) with additional trisomy 4 in acute myelogenous leukemia

Lee JH, Ha JS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
JAK2 V617F and the evolving paradigm of polycythemia vera

Means RT

Polycythemia vera (PV) was first described nearly 120 years ago. In the subsequent century, the clinical syndrome of PV, its natural history, its treatment, and many critical pathogenetic features of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development of acute myocardial infarction in a young female patient with essential thrombocythemia treated with anagrelide: a case report

Lim YH, Lee YY, Kim JH, Shin J, Lee JU, Kim KS, Kim SK, Kim JH, Lim HK

Essential thrombocythemia (ET) is a chronic myeloproliferative disorder with a prolonged clinical course. Since this disorder is considered to be at increased risk of thromboembolism, therapy is mainly focused on...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A variant acute promyelocytic leukemia with t(11;17) (q23;q12); ZBTB16-RARA showing typical morphology of classical acute promyelocytic leukemia

Han SB, Lim J, Kim Y, Kim HJ, Han K

A subgroup of acute leukemia with morphology resembling acute promyelocytic leukemia (APL) shows variant translocations involving RARA and has a different morphology from that of classical APL. The variant APL...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Improved outcome in childhood ALL with intensive consolidation and hematopoietic stem cell transplant

Park JA, Ghim T, Bae KW, Koh KN, Im HJ, Seo JJ

BACKGROUND: Despite advances in chemotherapy, the prognosis of relapsed acute lymphoblastic leukemia (ALL) remains poor. Few studies on relapsed ALL have reported the importance of intensive consolidation followed with or...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Time to establish multidisciplinary childhood cancer survivorship programs in Korea

Ghim TT

Improved treatment strategies and better supportive care have resulted in increased survival rates for childhood cancers. However, most of the survivors may have complex, long-term health issues. In 2004, Childhood...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Helicobacter pylori eradication in patients with immune thrombocytopenic purpura

Tag HS, Lee HS, Jung SH, Kim BK, Kim SB, Lee A, Lee JS, Shin SH, Kim YS

BACKGROUND: The relationship between Helicobacter pylori (H. pylori) infection and chronic idiopathic thrombocytopenic purpura (ITP) has been confirmed; however, no clear evidence for the effectiveness of H. pylori eradication on...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Soluble syndecan-1 at diagnosis and during follow up of multiple myeloma: a single institution study

Kim JM, Lee JA, Cho IS, Ihm CH

BACKGROUND: Syndecan-1 is a heparan sulfate proteoglycan expressed on plasma cells, especially myeloma cells, and can exist in serum as soluble syndecan-1 after shedding from the cell surface. Soluble syndecan-1...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Allogeneic hematopoietic cell transplantation for acute leukemia in first relapse or second remission

Lee JH, Yoon SS, Jung CW, Lee JH, Kim DY, Lee YS, Yun SC, Kim I, Park S, Kim BK, Kim K, Ahn JS, Lee KH

BACKGROUND: The role of pre-transplant salvage chemotherapy has been controversial in relapsed acute leukemia. METHODS: We investigated post-transplant outcomes in 65 patients with acute leukemia treated with allogeneic hematopoietic cell transplantation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Fludarabine-based myeloablative regimen as pretransplant conditioning therapy in adult acute leukemia/myelodysplastic syndrome: comparison with oral or intravenous busulfan with cyclophosphamide

Lee JH, Choi J, Kwon KA, Lee S, Oh SY, Kwon HC, Kim HJ, Han JY, Kim SH

BACKGROUND: A combination of busulfan (Bu) and cyclophosphamide (Cy) has been used as a standard myeloablative regimen for allogeneic hematopoietic stem cell transplantation (HSCT). Recent studies postulate that fludarabine (Flu)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Reduced-dose craniospinal radiotherapy followed by high-dose chemotherapy and autologous stem cell rescue for children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuroectodermal tumor

Kim SY, Sung KW, Hah JO, Yoo KH, Koo HH, Kang HJ, Park KD, Shin HY, Ahn HS, Im HJ, Seo JJ, Lim YJ, Lee YH, Shin HJ, Lim DH, Cho BK, Ra YS, Choi JU

BACKGROUND: In this study, we investigated the effects of reduced-dose craniospinal radiotherapy (CSRT) followed by tandem high-dose chemotherapy (HDCT) with autologous stem cell rescue (ASCR) in children with a newly...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr